BMJ  2008;336:693 (29 March), doi:10.1136/bmj.39527.454560.59

Observations

Border Crossing

Purely medicinal?

We must grasp the opportunity to respond to a controversial EU proposal to allow drug companies to provide information on prescription only drugs directly to the public

The first 150 words of the full text of this article appear below.

How easy is it to draw a clear line between providing information about a product and promoting it? Most of us would regard it as difficult, if not impossible. Not the European Commission, though—at least not when the product is a drug. This is evident in a new and already much criticised consultation paper on patient information (http://ec.europa.eu/enterprise/pharmaceuticals/index_en.htm). This paper sets out the commission’s ambitious proposals to provide Europe’s citizens with "uniform access to understandable, objective, high quality, and non-promotional information" on drugs. Central to these plans is a move to allow manufacturers to provide information on prescription drugs directly to the public, under the "clear safeguard" that advertisement is banned. Responses to the paper are invited to help inform a draft directive that will include proposals to reform the way drugs are assessed and priced. So why the criticism?

The answer lies in the history behind the . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

A cynical consultation exercise?

Charles Medawar
BMJ 2008 336: 787. [Extract] [Full Text] [PDF]

Include cost of treatment

Anthony N Glaser
BMJ 2008 336: 788. [Extract] [Full Text] [PDF]

Of medicine and medicines

Tony Delamothe
BMJ 2008 336: 0. [Extract] [Full Text]

Over the counter medicines: proceed with caution

Robin E Ferner and Keith Beard
BMJ 2008 336: 694-696. [Extract] [Full Text] [PDF]

Sweetening the pill

Hannah Brown
BMJ 2007 334: 664-666. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Glaser, A. N (2008). Include cost of treatment. BMJ 336: 788-788 [Full text]  
• Medawar, C. (2008). A cynical consultation exercise?. BMJ 336: 787-787 [Full text]  

Rapid Responses:

Read all Rapid Responses

Direct to consumer advertising

Anthony N Glaser
bmj.com, 29 Mar 2008 [Full text]

Misdirection by “truth”?

Mohamed Sakel
bmj.com, 30 Mar 2008 [Full text]

Americanisation

Neal J Russell
bmj.com, 3 Apr 2008 [Full text]

A cynical consultation exercise?

Charles Medawar
bmj.com, 4 Apr 2008 [Full text]

Starving for good quality info - flooded with misleading marketing

Norbert Wilk
bmj.com, 4 Apr 2008 [Full text]

Have we disposed of the need for evidence?

Daniel J Beck, et al.
bmj.com, 5 Apr 2008 [Full text]

DTC: Impossible to stop, once begun?

James B. Russo
bmj.com, 5 Apr 2008 [Full text]

Make all drugs OTC ! DTC is coming ! The day is not far away for patient guided prescription ?

venkatesan sangareddi, et al.
bmj.com, 11 Apr 2008 [Full text]